About the Webinar
 

CHO cells are the workhorse of most biologics manufacturing. Maximizing their productivity and viability is essential to decrease the cost of goods and increase access to treatments.  Using metabolomics to gain a deeper understanding of cell physiology and metabolism allows us to unlock improved performance and yield.  We will discuss opportunities and limitations of metabolomic workflows as applied to a bioprocess system. You will hear an example of how this data was applied to media development resulting in improved culture viability. Come learn how omics analyses can take your bioprocessing system to the next level!

About the Presenter

Erin Weisenhorn

Erin Weisenhorn
Senior Scientist II, Just - Evotec Biologics

Erin Weisenhorn has led the implementation of metabolomics at Just - Evotec Biologics using untargeted, targeted, and machine learning tools to improve bioprocess performance.  She is experienced in applying mass spectrometry to all phases of antibody manufacturing and characterization.  Erin received her PhD in Biochemistry at UW Madison and is currently based Seattle where she enjoys practicing dressage with her horse.  

If the webinar has not loaded above, please click the link here.

Therapeutic Areas:

Scientific Topics:

Resource Types: